The quinacrine controversy continues

Quinacrine is a non-surgical method of female sterilisation. It has not been approved by the drug regulatory authority in any country as studies have not yet shown whether it is safe or effective. A small number of individual doctors are continuing to provide this method to poor women in developing countries, in spite of international advice by the WHO, IPPF and other medical and scientific experts in the field. This report includes: 1) a summary of events in the past year, most importantly the finding of mutagenicity in three of the four pre-clinical toxicology tests on the drug and the issues these results raise for further research; 2) a paper by Lezak Shallat on the continuing provision of quinacrine sterilisation to women in Santiago, Chile

Developed country · Developing country · Economic growth · Environmental health · Family medicine · Political science · Population · Ethics and bioethics in healthcare · Medicine

• The Strategic Approach to Contraceptive Introduction

  Ruth Simmons, Peter Hall et al.•Studies in Family Planning•1997

  Incluir item

• Women's autonomy and its impact on fertility

  Open Access•Sousan Abadian•World Development•1996

  Incluir item

• The use of quinacrine pellets for non-surgical female sterilisation

  Amy E Pollack, Charles S Carignan•Reproductive Health Matters•1993

  Incluir item

• The quinacrine controversy one year on

  Marge Berer•Reproductive Health Matters•1994

  Incluir item